Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan C Lynch

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
American Journal of Hematology|May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapyVictor A Chow, Ajay K Gopal, David G Maloney, et al.
Blood|December 29, 2025
Brentuximab Vedotin and Nivolumab in Combination With Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin LymphomaJeremy S Abramson, David J Straus, Nancy L Bartlett, et al.
Blood|March 13, 2023
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphomaRyan C Lynch, Chaitra S Ujjani, Christina Poh, et al.
Blood|July 7, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysisMiguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, et al.
Blood|February 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cellsAlexandre V Hirayama, Jordan Gauthier, Kevin A Hay, et al.
Blood Advances|March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.
Nature Communications|May 26, 2026
An X-linked sex determination mechanism in cannabis and hopSarah B Carey, Philip C Bentz, John T Lovell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell LymphomaEdward R Scheffer Cliff, Guido D Pelaez, Fei Wan, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
An X-linked sex determination mechanism in cannabis and hopSarah B Carey, Philip C Bentz, John T Lovell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyRanjana H Advani, Christopher R Kelsey, Philippe Armand, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Hematology|May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapyVictor A Chow, Ajay K Gopal, David G Maloney, et al.
Blood|December 29, 2025
Brentuximab Vedotin and Nivolumab in Combination With Chemotherapy for Nonbulky, Early-Stage Classical Hodgkin LymphomaJeremy S Abramson, David J Straus, Nancy L Bartlett, et al.
Blood|March 13, 2023
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphomaRyan C Lynch, Chaitra S Ujjani, Christina Poh, et al.
Blood|July 7, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysisMiguel-Angel Perales, Farrukh T Awan, Ariane Boumendil, et al.
Blood|February 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cellsAlexandre V Hirayama, Jordan Gauthier, Kevin A Hay, et al.
Blood Advances|March 19, 2026
Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.
Nature Communications|May 26, 2026
An X-linked sex determination mechanism in cannabis and hopSarah B Carey, Philip C Bentz, John T Lovell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell LymphomaEdward R Scheffer Cliff, Guido D Pelaez, Fei Wan, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
An X-linked sex determination mechanism in cannabis and hopSarah B Carey, Philip C Bentz, John T Lovell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In OncologyRanjana H Advani, Christopher R Kelsey, Philippe Armand, et al.
Pageof 8